A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).
about
Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individualsComparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort studyEfficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novaviIncreased bone resorption during tenofovir plus lopinavir/ritonavir therapy in Chinese individuals with HIVThe reassurance of experience.Initial antiretroviral therapy in chronically-infected HIV-positive adults.Lopinavir plus ritonavir: a novel protease inhibitor combination for HIV infections.Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment.Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events.Early warning indicators for first-line virologic failure independent of adherence measures in a South African urban clinic.Immunological profile in persons under antiretroviral therapy in a rural Nigerian hospital.Drug safety evaluation profile of stavudine plus lamivudine for HIV-1/AIDS infection.Stavudine extended release (once-daily, Bristol-Myers Squibb) for the treatment of HIV/AIDS.Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia.Resistance costs and future drug options of antiretroviral therapies: analysis of the role of NRTIs, NNRTIs, and PIs in a large clinical cohort.Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study.Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter.Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons.Incorporating durability information in the comparison of proportions of patients with HIV suppression.Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection.
P2860
Q24236476-21393876-AC68-419B-AA86-CAD7BBE5DFD9Q28487986-713F8EBB-1432-4508-B79C-3EAC3AAEF03EQ34109417-939F45CB-8B87-4AD1-BACC-6B6DA5ECCD2AQ35102114-190DA7EA-57FA-4CCF-8FB7-7147CEC38FEFQ35583703-69B7668E-00E9-41F3-A83E-E484496886FAQ35688173-8A2FA602-78E3-4E10-8F67-7AA746BEB130Q36723780-8D78E31D-5CCD-46EE-9D31-57C3E99D72B1Q36765799-36711234-9BA9-434A-BAC7-A28C08561446Q37047864-09EF4390-1F21-4512-B8C5-2B77B47F1AF2Q37403995-0BC02ACC-6A2F-4B0E-BD81-B39864C1647EQ37692805-6CF759FD-2161-422E-82B1-99F8879C512BQ37999051-512E2FB8-5047-4F7A-B2E2-D2D6A111BE29Q38091148-AD22B137-7DEE-4447-8170-82DBD18D529EQ39550582-F59FF857-4C5F-4307-AFF6-F883DE791C20Q40223246-F717FC2C-4670-405A-84CD-1151F1A34876Q41219108-14B6C9FD-DEC4-40AA-B5BF-F046F2F3C811Q43871655-C911537F-B359-4A74-BC8D-AB3576ACBECEQ45245260-84FE80A8-4B08-46A7-8F8A-B70C628F6AF0Q50487955-DC5697C1-9E0A-47EA-BFA8-F60D9717733FQ52374199-0E76B155-1C1E-4E35-973B-BC509C5AA910
P2860
A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
A comparison of stavudine plus ...... log regimen therapy (START I).
@en
A comparison of stavudine plus ...... ymidine analog regimen therapy
@nl
type
label
A comparison of stavudine plus ...... log regimen therapy (START I).
@en
A comparison of stavudine plus ...... ymidine analog regimen therapy
@nl
prefLabel
A comparison of stavudine plus ...... log regimen therapy (START I).
@en
A comparison of stavudine plus ...... ymidine analog regimen therapy
@nl
P2093
P1433
P1476
A comparison of stavudine plus ...... alog regimen therapy (START I)
@en
P2093
K E Squires
K Uffelman
N Schoellkopf
P304
P356
10.1097/00002030-200007280-00015
P407
P577
2000-07-01T00:00:00Z